Phthalates: Health Effects, Exposure and Regulation

Phthalates are diesters of ortho-phthalic acid that are blended into PVC to make it soft, and that are not chemically bound to the polymer, so they migrate out of it over the product's life. Western Europe alone produces about 1 million tonnes of them a year, of which more than 900,000 tonnes go into PVC, according to European Plasticisers. That single physical fact, an additive that is dissolved in a plastic rather than attached to it, explains both why phthalates made flexible vinyl possible in 1926 and why 4 of them are now capped at 0.1 % by weight in every article sold in the European Union.

The health question turns on which phthalate, at what dose and by which route. Four low molecular weight esters, DEHP, DBP, BBP and DIBP, carry a harmonised EU classification for reproductive toxicity and sit on the REACH Authorisation List. The high molecular weight esters that replaced them in flooring, cable and coated fabric, DINP and DIDP, carry no reproductive-toxicity classification after the ECHA Risk Assessment Committee opinion of 9 March 2018, and the US EPA found no unreasonable risk to consumers for either of them in January 2025.

Phthalates are one class within the plasticizer family of plastic additives, and they are the most heavily regulated class of any additive used in plastics. About 5.5 million tonnes were produced worldwide in 2015, up from roughly 2.7 million tonnes in the 1980s, on figures compiled by Holland for the OECD in 2018. This page sets out what phthalates are, where they occur, how people take them in, what the human and animal studies actually found, and what each jurisdiction limits, with the instrument and date for every rule.

In brief:

• DEHP, DBP, BBP and DIBP have been limited to 0.1 % by weight in the plasticized material of all articles in the EU since 7 July 2020, under REACH Annex XVII entry 51.
• DINP, DIDP and DNOP are limited to 0.1 % only in toys and childcare articles that a child can put in the mouth (entry 52). DINP is not banned in the EU.
• EU food-contact limits were tightened by Regulation (EU) 2023/1442, in force 1 August 2023: DEHP 0.6 mg/kg, DBP 0.12 mg/kg, BBP 6 mg/kg, DINP plus DIDP 1.8 mg/kg.
• Phthalate biological half-lives are below 24 hours, so a spot urine sample measures recent exposure, not body burden.
• DEHP is classified by IARC in Group 2B, and DEHP use in EU medical devices ends at the sunset date of 1 July 2030.

What Are Phthalates?#

A phthalate is an ester formed from ortho-phthalic acid (benzene-1,2-dicarboxylic acid) and two alcohol chains, used in plastics to lower the glass transition temperature of a rigid polymer and make it flexible. The two alcohol chains determine everything that matters about the molecule: its compatibility with PVC, its volatility, how fast it leaves the plastic and how the body metabolises it. US EPA usage defines a phthalate as a dialkyl ortho-phthalate ester, which is why para-substituted esters such as DOTP fall outside the term in both EU and US regulation.

Phthalates are consumer chemistry only in the sense that consumers meet the products that contain them. In the industry they are one of 14 chemical classes of plasticizers for plastics, alongside terephthalates, trimellitates, adipates, cyclohexanoates, epoxidized oils, polymerics, benzoates, citrates and phosphates. S&P Global's December 2024 Chemical Economics Handbook forecasts that ortho-phthalates still hold 52.4 % of the global plasticizer market in 2029, so the class is shrinking rather than disappearing.

Which phthalates are used in plastics?#

Twelve ortho-phthalates carry commercial volume in plastics, and 4 of them account for most of the regulatory attention. The list below separates the low molecular weight esters, which are restricted in the EU, from the high molecular weight esters, which are not. Further identity, dosage and supplier detail for each ester sits on the class page for phthalate plasticizers.

Dimethyl phthalate (DMP, CAS 131-11-3) belongs to the same short-chain group as DEP and is used to plasticize cellulose esters and to carry MEKP peroxides at 40 to 60 % solution strength. Neither DMP nor DEP is an SVHC.

Low and high molecular weight phthalate plasticizers#

The industry splits phthalates by the length of the alcohol chain, and the split predicts the toxicology closely enough that regulators use it too. European Plasticisers defines low molecular weight phthalates as esters with 3 to 6 carbon atoms in the alcohol backbone, which covers DEHP, DBP, DIBP and BBP, and high molecular weight phthalates as esters with 7 to 13 carbon atoms, which covers DINP, DIDP, DPHP, DIUP and DTDP.

That distinction is now the shape of the European market. High molecular weight esters make up about 85 % of Western European ortho-phthalate production, and low molecular weight esters under 11 %, on European Plasticisers figures. The reason is regulatory rather than technical: every ester in the low molecular weight group carries a harmonised CLP classification for reproductive toxicity, while the ECHA Risk Assessment Committee concluded on 9 March 2018 that no classification for reproductive toxicity is warranted for DINP.

Chain length also changes the physics. Longer and more branched alcohol chains lower polarity, which reduces compatibility with PVC and processability, raises viscosity, lowers volatility and improves low-temperature flexibility. Low volatility is the property that matters most for exposure, because it slows the rate at which the ester leaves a warm plastic article into indoor air. The same chain-length logic governs every other ester class on the hub for plasticizers for plastics, from adipates to trimellitates.

Why phthalates leave the plastic they soften#

Phthalates leave plastics because they are dissolved in the polymer matrix rather than bonded to it, so they migrate into contacting material, volatilise into air and are extracted by fats and oils. A plasticizer works by pushing PVC chains apart and screening the dipole attractions between them, which requires the molecule to stay mobile inside the matrix. Mobility and permanence are therefore opposite ends of the same property, and no ester plasticizer achieves both.

Loading levels make the mass involved large. Flexible PVC contains 5 to 65 wt% plasticizer at a hardness of 50 to 90 Shore A, a range Wiesinger and colleagues at ETH Zurich confirmed in Environmental Science and Technology in 2024. Bernard and colleagues measured 34.9 to 48.7 wt% DINP in French PVC medical lines in PLoS One in 2018, which means that in a plasticized medical tube, nearly half the material by weight is a small molecule capable of moving. The mechanics of that movement, including diffusion coefficients, food simulants and the effect of fat content, are set out under additive migration in plastics.

Three transport routes carry phthalates out of an article, and each dominates a different exposure setting.

• Migration into a contacting phase: food, blood, saliva or another plastic in the stack. This route dominates food-contact and medical exposure, and it accelerates with fat content and temperature.
• Volatilisation into air: slow, because phthalates have extremely low vapour pressures, but continuous over the decades a vinyl floor or a cable jacket stays in service. Volatilised ester condenses onto dust.
• Extraction by solvents and oils: the route measured by ASTM D1239, using hexane, soapy water and mineral oil, and the reason fatty foods pick up more DEHP than aqueous ones.

Are phthalates and plasticizers the same thing?#

Phthalates and plasticizers are not the same thing, because phthalates are one chemical class of plasticizer among 14, and most commercial plasticizer classes are not phthalates. A plasticizer is defined in ASTM D883 as a substance incorporated into a plastic or elastomer to increase its flexibility, workability or distensibility, which covers terephthalates, trimellitates, adipates, cyclohexanoates, citrates, benzoates, phosphates, epoxidized oils and polymeric polyesters as well. The confusion matters commercially, because a product labelled phthalate-free almost always still contains a plasticizer.

Where Phthalates Are Found in Everyday Products#

Phthalates occur wherever flexible PVC occurs, which in practice means flooring, wall covering, cable sheathing, coated fabric, medical tubing, garden hose, gaskets and film. More than 900,000 tonnes of the roughly 1 million tonnes of phthalates produced in Western Europe each year go into PVC, so the material and the additive are effectively one story. Each ester is matched to an application by volatility and permanence rather than by cost alone.

The products most often associated with each commercial ester are listed below.

• DEHP: medical tubing and blood bags, legacy flooring, legacy wire and cable, coated fabrics, capacitor dielectric film.
• DINP: flooring, wire and cable, garden hose, coated fabrics, adhesives and sealants, and toys outside the mouthable category in the EU.
• DIDP and DPHP: wire and cable insulation, automotive interiors and undercoating, calendered film, roofing membranes.
• DBP, BBP and DIBP: printing inks, nitrocellulose lacquers, PVAc adhesives, vinyl floor tiles and cellulose plastics, all largely legacy uses in the EU.
• DEP and DMP: cellulose acetate articles, and DMP additionally as the carrier solvent for organic peroxides.

Flexible PVC: the material behind most phthalate use#

Flexible PVC is the material that carries nearly all phthalate volume, because PVC is the only large-volume polymer that accepts 30 wt% or more of a small-molecule ester without losing mechanical integrity. Waldo Semon at B.F. Goodrich plasticized PVC in 1926, and dibutyl phthalate was in use as the softener by 1933, which makes phthalate-plasticized vinyl one of the oldest continuously produced additive systems in plastics. A full PVC compound also carries a heat stabilizer, lubricants, fillers and pigments, and the interactions between them are set out under additives for PVC.

Plasticizer choice is application-driven. Cable jackets need low volatility, so they use DIDP, DPHP or DTDP. Medical tubing needs extractability control and gamma-sterilisation stability, which pushed the sector from DEHP to TOTM, DEHT and DINCH. Flooring needs fusion speed and cost, which is why DINP replaced DEHP there in a near one-to-one substitution, as Klotz and colleagues documented in 2024. Compound-level detail for each of these product groups sits under flexible PVC formulations.

Phthalates in food#

Phthalates reach food mainly through processing equipment and packaging rather than through the food itself, and diet is the dominant exposure route for DEHP and the high molecular weight esters in the general population. PVC tubing, gaskets, conveyor belts and closure liners all contact food during manufacture, and fatty foods extract more ester than aqueous ones because phthalates are lipophilic. Zota and colleagues, analysing NHANES 2003 to 2010 in Environmental Health Perspectives in 2016, found recent fast-food consumption associated with higher urinary DEHP and DINP metabolite concentrations.

EU law controls this route with specific migration limits rather than composition limits, so a phthalate may be present in a food-contact plastic as long as what reaches the food stays below the limit. Which esters are permitted in which contact conditions, and the plasticizer group limit of 60 mg/kg that applies on top of the individual values, are covered under additives for food packaging. The wider question of what else migrates from packaging is answered under chemicals migrating from plastic food packaging.

How People Are Exposed to Phthalates#

Four exposure routes carry phthalates into the human body: diet, medical devices, indoor dust and air, and personal care products. Their relative importance depends on the ester. Diet dominates for DEHP, DINP and DIDP, medical treatment dominates for patients on intensive PVC-based therapy, dust matters for small children with high hand-to-mouth contact, and fragrance dominates for DEP. Because the esters differ, a single number for total phthalate exposure has no meaning without naming which substance it refers to.

Diet as the dominant route#

Diet delivers most of the DEHP and high molecular weight phthalate intake in the general population. The transfer happens during processing and packaging: PVC tubing and gaskets in dairy and meat production, plasticized closure liners on glass jars, and printed or laminated films in contact with fatty products. Cooking oil, dairy fat and meat fat are the efficient carriers, since the esters dissolve far better in lipid than in water.

Measured intake varies with the diet rather than with the packaging alone. In the NHANES analysis by Zota and colleagues at the University of California, San Francisco, published in Environmental Health Perspectives in 2016, participants who reported recent fast-food consumption had higher urinary metabolites of both DEHP and DINP than those who did not, with the association strongest for grain and meat items. Fast food involves more processing contact surfaces per calorie, which is the mechanism the authors proposed.

Medical devices: the DEHP exposure route with the highest doses#

Medical devices deliver the highest documented phthalate doses, because DEHP-plasticized PVC delivers the ester directly into blood or into the gastrointestinal tract rather than through a food matrix. The US Food and Drug Administration estimated an upper-bound DEHP dose of about 3,000 µg/kg/day for a 4 kg neonate in intensive care, against a parenteral tolerable intake of 0.6 mg/kg/day, a ratio of roughly 5 to 1 above the tolerable value. DEHP content in PVC medical devices reaches up to 40 wt%.

The FDA issued a Public Health Notification on DEHP in PVC medical devices on 12 July 2002, recommending DEHP-free alternatives for male neonates, for pregnant women carrying male fetuses and for peripubertal males. Substitution is harder in blood bags than elsewhere, because DEHP stabilises red cell membranes and reduces haemolysis during storage, a benefit the replacement esters do not reproduce automatically. Device-side formulation choices, including the gamma and steam sterilisation constraints that narrow the list of usable plasticizers, are covered under additives for medical plastics and DEHP-free PVC.

EU law now sets an end date for this use. Under Regulation (EU) 2023/2482, the latest application date for authorisation of DEHP in medical devices is 1 January 2029 and the sunset date is 1 July 2030, replacing the earlier dates of 27 November 2023 and 27 May 2025. Regulation (EU) 2017/745 on medical devices separately requires, in Annex I section 10.4, that any CMR category 1A or 1B substance or endocrine disruptor present above 0.1 % w/w be justified and labelled.

Indoor dust, air and skin contact#

Indoor dust carries phthalates that have volatilised or abraded from vinyl flooring, wall covering and cable insulation, and it is the route that matters most for toddlers. The esters have extremely low vapour pressure, so the airborne fraction is small, but emission continues for the whole service life of the article and the released molecules partition onto airborne particles and settled dust. Hand-to-mouth contact then converts dust loading into ingested dose.

Skin contact contributes less for the high molecular weight esters, which cross skin poorly, and more for the short-chain esters used in cosmetics. DEP is the relevant ester for dermal exposure, and its use is in fragrance rather than in plastics, which places it outside the plastics scope of this reference.

How phthalate exposure is measured#

Phthalate exposure is measured as urinary metabolites, not as the parent ester, because the diesters hydrolyse rapidly to monoesters and oxidised metabolites after absorption. The US Centers for Disease Control and Prevention has tracked these metabolites in the National Health and Nutrition Examination Survey since the late 1990s, which is why phthalate data exist for representative populations rather than only for occupational cohorts.

Interpretation is limited by kinetics. Phthalate biological half-lives are below 24 hours, so a single spot urine sample reflects the previous day's exposure, not accumulated body burden, and day-to-day variability in the same person is high. Ubiquitous detection therefore means ubiquitous recent contact, not accumulation. Analytical methods for the parent esters in the plastic itself, rather than in urine, are different again and are covered under phthalate testing in plastics.

Are Phthalates Harmful? What the Studies Show#

The evidence differs by ester and by endpoint, and the strongest findings concern male reproductive development after exposure in the womb. Animal studies establish a causal mechanism for four low molecular weight esters, human studies show consistent associations with the same endpoints, and observational cohort analyses report associations with mortality that are not evidence of causation. Regulators have acted on the animal and mechanistic evidence, which is why DEHP, DBP, BBP and DIBP carry a harmonised EU classification while DINP does not.

Phthalate syndrome and male reproductive development#

Phthalate syndrome is the cluster of male reproductive effects seen in rats exposed in the womb to DEHP, DBP, BBP or DIBP: reduced fetal testosterone, hypospadias, cryptorchidism, shortened anogenital distance and nipple retention. Paul Foster set out the syndrome and its mechanism in the International Journal of Andrology in 2006, in "Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters". The common mechanism is suppression of testosterone synthesis in the fetal testis during the window in which the male reproductive tract forms.

Human evidence points the same way without proving cause. Shanna Swan and colleagues at the University of Rochester measured prenatal urinary phthalate metabolites and infant anogenital distance in 85 mother and son pairs, reporting in Environmental Health Perspectives in 2005, in "Decrease in anogenital distance among male infants with prenatal phthalate exposure", an odds ratio of 10.2 for a short anogenital index in the top versus the bottom quartile of the DBP metabolite MBP, with a 95 % confidence interval of 2.5 to 42.2. The confidence interval is wide because the study is small, and the finding is an association in a cohort of 85, not a controlled experiment.

The regulatory consequence is concrete. DEHP carries the harmonised CLP classification H360FD, meaning it may damage fertility and may damage the unborn child. DBP, BBP and DIBP carry H360Df, and DCHP carries H360D together with a skin sensitisation statement. Those classifications, not the epidemiology, are the legal basis for the REACH Candidate List entries of 28 October 2008 for DEHP, DBP and BBP, 13 January 2010 for DIBP and 27 June 2018 for DCHP. The wider class of substances assessed for this kind of hormonal activity is covered under endocrine disruptors in plastics.

Mortality: what the 2021 NHANES analysis found#

The published mortality finding is an association, not a demonstration of cause. Leonardo Trasande, Buyun Liu and Wei Bao of New York University analysed NHANES data from 2001 to 2010 for 5,303 adults with mortality follow-up to 2015, and reported in Environmental Pollution in 2021 a hazard ratio of 1.14 for all-cause mortality per unit increase in high molecular weight phthalate metabolites, with a 95 % confidence interval of 1.06 to 1.23, and 1.10 for DEHP metabolites.

The widely quoted figures are extrapolations from that hazard ratio. The authors estimated 90,761 to 107,283 attributable deaths among US adults aged 55 to 64 and USD 39.9 to 47.1 billion in lost economic productivity. Those numbers depend on the assumption that the association is causal, which the study design cannot test, and they are not a measured death count. Reported as a measured toll, they misstate what the analysis did.

Cancer classifications#

DEHP is classified by the International Agency for Research on Cancer in Group 2B, possibly carcinogenic to humans. The classification rests on rodent liver tumour data, and Group 2B is the category IARC uses where human evidence is inadequate. California listed DEHP under Proposition 65 for cancer on 1 January 1988 and for developmental and male reproductive toxicity on 24 October 2003.

DINP carries a different profile. It has no harmonised CLP classification, and 895 of 901 notifying companies report it as not meeting GHS hazard criteria in the ECHA classification and labelling inventory. California nonetheless listed DINP for cancer on 20 December 2013, with a no significant risk level of 146 µg/day revised on 1 April 2016. The two outcomes are not contradictory: they apply different evidence thresholds, and only the Proposition 65 listing carries a warning obligation in California. Listing dates for every plastic additive on that list are on California Proposition 65.

What the evidence does not establish#

Four claims about phthalates are common in consumer coverage and are not established by the sources this reference uses. Naming them matters, because a reference page that repeats them loses the ability to be precise about the claims that are supported.

1. A single tolerable daily intake for phthalates as a group. This page states no group tolerable daily intake, because the value circulating in secondary literature is not verified here against the primary opinion. EU food-contact control operates through specific migration limits instead.
2. Trends in population exposure over time. Statements that DEHP metabolites have fallen while DINP and DEHT metabolites have risen since 2005 are plausible from the substitution pattern, but the underlying survey series is not verified in our source library and is therefore not stated as fact.
3. Asthma, obesity, neurodevelopmental and preterm-birth effects. Associations are reported across the literature, and the evidence is mixed. No causal conclusion is drawn here.
4. A global figure for the share of phthalates used in PVC. Secondary sources give 90 to 95 %. The verified figure is regional: more than 900,000 tonnes of Western Europe's roughly 1 million tonnes per year, from European Plasticisers.

How Phthalates Are Regulated#

Phthalate regulation works through four distinct mechanisms: composition limits in articles, migration limits for food contact, authorisation requirements for continued use, and hazard classification with warning duties. A substance can be unrestricted under one mechanism and banned under another, which is why "is this phthalate legal" has no answer without naming the jurisdiction and the product.

The comparison table below gives the EU and US position for the 6 esters with the largest regulatory footprint. Product-by-product scope, exemptions and derogations across every jurisdiction are covered under phthalate restrictions worldwide.

EU rules: REACH, food contact, toys and medical devices#

EU law restricts phthalates through five instruments, and REACH Annex XVII entry 51 is the broadest. Since 7 July 2020, under Commission Regulation (EU) 2018/2005, DEHP, DBP, BBP and DIBP are limited to 0.1 % by weight, individually or in any combination, in the plasticized material of articles. The limit previously applied only to toys and childcare articles. Exemptions cover articles for exclusively industrial or agricultural use, motor vehicles, aircraft, laboratory measuring devices and medical devices, which is why phthalate-containing legacy equipment remains lawful in those settings.

Entry 52 is narrower and often misreported. It limits DINP, DIDP and DNOP to 0.1 % by weight only in toys and childcare articles that children can place in the mouth. No EU instrument bans DINP in general articles. The full set of entries that touch plastic additives, including entries 23, 50, 51, 52, 63, 78 and 79, is set out under REACH Annex XVII restrictions on plastic additives.

Authorisation works differently from restriction. DEHP, BBP, DBP and DIBP occupy entries 4 to 7 of REACH Annex XIV, with a latest application date of 21 August 2013 and a sunset date of 21 February 2015, after which use in the EU requires a granted authorisation. Regulation (EU) 2021/2045, published in OJ L 418 on 24 November 2021, added endocrine-disrupting properties under Article 57(f) to those four entries, with derogation dates of 14 June 2023 and 14 December 2024 for previously exempt uses. The Authorisation List holds 14 phthalate entries in total, verified against the consolidated Annex XIV of 22 June 2026. Sunset dates for every listed additive are tabulated under the REACH Annex XIV authorisation list.

Food contact is governed by Regulation (EU) No 10/2011, amended for phthalates by Regulation (EU) 2023/1442, in force since 1 August 2023. That amendment cut the specific migration limits to 0.6 mg/kg for DEHP, 0.12 mg/kg for DBP and 6 mg/kg for BBP, cut the group 26 limit for DINP plus DIDP from 9 to 1.8 mg/kg, and created group restriction 36, a total of 0.6 mg/kg expressed as DEHP equivalents using the weightings DBP multiplied by 5, DIBP by 4, BBP by 0.1 and DEHP by 1. Group restriction 32, covering plasticizers as a class at 60 mg/kg, was unchanged. Non-compliant materials placed on the market before the amendment could remain until 1 February 2025. The Union list mechanism, the overall migration limit and the functional-barrier rule are explained under EU 10/2011.

Two further instruments complete the picture. Directive (EU) 2015/863 (RoHS) restricts DEHP, BBP, DBP and DIBP to 0.1 % in homogeneous materials of electrical and electronic equipment, from 22 July 2019 for most categories and 22 July 2021 for categories 8 and 9. Regulation (EU) 2025/2509 on toy safety, adopted 26 November 2025 and published in the Official Journal on 12 December 2025, bans CMR substances and endocrine disruptors in toys generically; it applies from 1 August 2030, with Articles 28 to 44 and 49 to 55 applying from 1 January 2026. What is permitted in children's products in the meantime is covered under additives in toys and childcare articles.

US rules: CPSIA, FDA, TSCA and Proposition 65#

US federal control of phthalates is split across three agencies with different scopes, and no single federal ban exists. The Consumer Product Safety Commission prohibits 8 phthalates above 0.1 % in children's toys and child care articles under 16 CFR 1307: DEHP, DBP and BBP permanently under 1307.3(a), and DINP, DIBP, DPENP, DHEXP and DCHP under 1307.3(b) by the final rule of 27 October 2017, effective 25 April 2018. DIDP and DNOP are not restricted by that rule. Test methods and the exemption pathway for plastics under 16 CFR 1308 are covered under CPSIA phthalate limits.

The Food and Drug Administration regulates the same chemistry as food-contact substances. Its final rule of 20 May 2022, published at 87 FR 31080, removed 25 authorisations covering 23 phthalates and 2 other substances, leaving exactly 8 ortho-phthalates authorised as plasticizers: DINP, DIDP, DEHP, DCHP, BPBG, DEP, EPEG and DIOP, plus diallyl phthalate as a monomer. On 27 May 2026 the FDA advanced a post-market review proposing a cumulative assessment group of DEHP, DCHP, DIOP and DINP under docket FDA-2026-N-5776, with the comment period extended to 26 July 2026. That action is a proposal, not a ban, and the 8 authorisations stand.

The Environmental Protection Agency assesses the same substances for risk rather than for food safety. Final TSCA risk evaluations for BBP, DBP, DCHP, DEHP and DIBP were released in December 2025, with the Federal Register notice of availability dated 6 January 2026 at 91 FR 373, finding unreasonable risk driven by specific conditions of use. For DINP, the notice of 15 January 2025 at 90 FR 3828 found unreasonable risk to workers from 4 conditions of use, all spray applications, and no consumer, general-population or environmental risk. For DIDP, the notice of 6 January 2025 at 90 FR 638 found unreasonable risk to female workers of reproductive age from 6 of 49 conditions of use. A risk finding is the trigger for rulemaking, not a restriction in itself, as explained under TSCA and plastic additives.

California operates the fourth mechanism, a warning duty rather than a limit. Proposition 65 lists DEHP for cancer since 1 January 1988 and for developmental and male reproductive toxicity since 24 October 2003, DBP since 2 December 2005, BBP for developmental toxicity since 2 December 2005, DIDP for developmental toxicity since 20 April 2007 and DINP for cancer since 20 December 2013. DIBP and DCHP are not listed, on the OEHHA list of 31 July 2026.

Canada, Japan and China#

Three further jurisdictions set phthalate limits in children's products, and all three use the same 0.1 % threshold as the EU and US. Canada's SOR/2016-188, in force since 22 June 2016, limits DEHP, DBP and BBP to 1,000 mg/kg in the vinyl of toys and child care articles, and DINP, DIDP and DNOP to 1,000 mg/kg in parts that a child under 4 years can mouth.

Japan applies MHLW Notification 336, issued 6 September 2010 and applicable from 6 September 2011, which limits DEHP, DBP and BBP to 0.1 % by mass in designated toys and DINP, DIDP and DNOP to 0.1 % in mouthable parts, and additionally bars DINP from PVC toy materials. China's revised toy safety standard GB 6675-2025 takes effect on 1 November 2026 with tightened phthalate requirements; the exact limit values are not captured in this reference and are therefore not stated.

How Industry Replaced Phthalates#

Industry replaced the restricted phthalates with four ester families, and the substitution was driven by regulation rather than by performance gain. Terephthalates, cyclohexane dicarboxylates, trimellitates and citrates now cover the applications that DEHP, DBP and BBP once held, and the European market shifted to high molecular weight ortho-phthalates for everything that did not need a non-phthalate label. The chemical logic is consistent across the four families: keep the ester structure that makes a good plasticizer, change the part of the molecule that the body metabolises into the active monoester.

DOTP illustrates the mechanism. Moving the second ester group from the ortho to the para position, as in bis(2-ethylhexyl) terephthalate, preserves DEHP-like solvating power and efficiency while removing the stable monoester associated with phthalate toxicity, and the Danish Environmental Protection Agency counts it among the three most promising alternatives together with DINCH and COMGHA. Selection criteria, cost-in-use and the performance trade-offs of each family are set out under non-phthalate plasticizers.

Medical devices show how far the substitution has gone. The European Pharmacopoeia lists 4 alternatives to DEHP for PVC blood containers: DINCH, BTHC, TOTM and DEHT. Bernard and colleagues measured the replacements at work in French hospital lines in 2018, finding 30 to 41 wt% TOTM, 26.7 to 37.5 wt% DEHT and 30.2 to 44.3 wt% DINCH, loadings comparable to the DEHP levels they replaced. Two further classes, terephthalate plasticizers and cyclohexane dicarboxylate plasticizers, have their own class pages with the full property comparison.

How long do phthalates stay in the body?#

Phthalates leave the body within about a day, because the diesters are hydrolysed to monoesters, partly oxidised, conjugated and excreted in urine with biological half-lives below 24 hours. No phthalate accumulates in fat the way a persistent organic pollutant does, which is the central difference between phthalate toxicology and POP toxicology. Continuous detection in populations therefore reflects continuous re-exposure rather than a stored burden, and reducing contact lowers measured metabolites within days.

Is DOTP a phthalate?#

DOTP is not a phthalate in regulatory usage, because it is a terephthalate, an ester of the para-substituted benzene-1,4-dicarboxylic acid rather than of ortho-phthalic acid. US EPA usage defines a phthalate as a dialkyl ortho-phthalate ester, and DOTP (CAS 6422-86-2, also called DEHT or DEHTP) sits outside that definition, which is why products plasticized with it are lawfully described as phthalate-free. The name causes confusion because "dioctyl terephthalate" reads like "dioctyl phthalate", the trade name for DEHP.

What does a "phthalate-free" label mean?#

Phthalate-free has no legal definition in either the EU or the US, so the claim describes composition rather than a regulatory status. In practice it means that the article contains no ortho-phthalate above the analytical reporting limit, and it carries no implication about the substance used instead, which is almost always another plasticizer such as DOTP, DINCH or a citrate. The claim, its legal anchors and the substitution questions it raises are examined under phthalate-free plastics.

Phthalates in recycled PVC#

Recycled PVC carries legacy phthalates that were lawful when the original article was made, which makes recyclate the main route by which restricted esters re-enter new products. Wiesinger and colleagues at ETH Zurich tested 151 new PVC floorings on the Swiss market and reported in Environmental Science and Technology in 2024 that 16 % contained regulated substances above 0.1 wt%, mainly lead and DEHP, and that 29 % contained other ortho-phthalates above 0.1 wt%. DEHP was detected in 19 % of samples, at 0.003 to 20 wt%.

The problem persists without intervention. Klotz and colleagues modelled Swiss PVC flooring flows in Environmental Science and Technology in 2024 and found that, without phthalate removal during recycling, DEHP stays above the 0.1 wt% threshold in recycled flooring for decades as recycling rates rise. Formulation strategies for recyclate, including what can be corrected with additives and what cannot, are covered under additives for recycled plastics, and the wider legacy-substance problem under legacy additives in recycled plastic.

Phthalates in fragrance, cosmetics and clothing#

Phthalates in fragrance and cosmetics are a different exposure story from phthalates in plastics, and they involve a different ester. DEP is the fragrance carrier, its metabolite MEP is the marker in urine, and its route is dermal and inhalation rather than dietary. Printed plastisol on textiles can contain phthalates, which is why phthalates are detected in printed garments, but textile finishing chemistry falls outside the plastics scope of this reference.

How is phthalate pronounced?#

Phthalate is pronounced with a silent "ph", giving roughly "THAL-ate" in British usage and "THAL-ate" or "FTHAL-ate" in North American usage. The spelling comes from naphthalene, the feedstock from which phthalic anhydride was originally made by oxidation.

Are phthalates the same as BPA?#

Phthalates and bisphenol A are different substances with different roles in plastics. A phthalate is an additive dissolved in PVC to soften it, while BPA is a monomer built into the polymer backbone of polycarbonate and epoxy resins, which is why BPA exposure depends on polymer hydrolysis rather than on migration of a free molecule. Their regulatory histories diverge accordingly, as set out under bisphenols in plastics. Both belong to the broader group covered under toxic plastic additives.

A short history of phthalates in plastics#

Phthalates entered plastics with flexible PVC in the 1920s and have been in continuous large-scale use ever since. Waldo Semon at B.F. Goodrich plasticized PVC in 1926, dibutyl phthalate was in use as the softener by 1933, and commercial DEHP production began in Japan around 1933 and in the United States in 1939. Production grew from roughly 2.7 million tonnes in the 1980s to about 5.5 million tonnes in 2015.

The regulatory phase began 70 years after the chemistry. DEHP, DBP and BBP reached the REACH Candidate List on 28 October 2008, entered Annex XIV with a sunset date of 21 February 2015, and were extended from toys to all articles on 7 July 2020. ECHA's PVC investigation of November 2023 reviewed 63 PVC additives and recommended restricting ortho-phthalate plasticizers and organotin stabilisers rather than PVC itself, which is the direction EU policy has followed since.